Palatin Technologies, Inc. (PTN) Announces Start of Second Phase I Trial of Its Obesity Compound
Palatin Technologies is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs…